Dementia with Lewy Bodies

Next steps in dementia biomarkers

Phase II study of S2R modulation in patients with dementia with Lewy bodies

Biomarkers in dementia with Lewy bodies: αSyn RT-QuIC

Diagnostic performance of GFAP in CSF, plasma, and serum with age

Characterizing the prodromal phase of dementia with Lewy bodies

A practical approach to cognitive impairment management

Diagnostic tools for neurodegenerative disease

Clinical characteristics of dementia with Lewy bodies

Criteria for the diagnosis and management of dementia with Lewy bodies

Combining gait with other biomarkers for dementia

The future landscape of biomarkers for dementia diagnosis

Gait & dementia: tool to aid clinical decision-making and diagnosis

Gait as a differential marker of dementia disease subtype

Unmets needs in Lewy body dementia: the neuropathologist’s perspective

The differentiation between Lewy body and Parkinson’s disease dementia

Post-translational modifications of alpha-synuclein in dementia with Lewy bodies